Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-13

Clinical Trial Update: Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vinflunine plus capecitabine in advanced breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Vinflunine (vinflunine)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-09-13